Researcher
Loes van Schie
- Keywords (Ghent University):protein therapeutics, Protein Engineering, infectious disease
- Disciplines (Flanders Institute for Biotechnology):Analytical biochemistry, Cell death and senescence, Analysis of next-generation sequence data, General diagnostics
- Disciplines (Ghent University):Proteins, Infectious diseases, Molecular and cell biology not elsewhere classified, Posttranslational modifications, Medical biotechnology not elsewhere classified
Affiliations
- Callewaert Lab (Research group)
Member
From1 Jan 2017 → Today - Department of Biomedical molecular biology (Department)
Member
From1 Oct 2013 → 31 Dec 2013 - Department of Biochemistry and microbiology (Department)
Member
From13 Sep 2013 → Today
Projects
1 - 1 of 1
- Fight against Mycobacterium tuberculosis infection with cell wall enzymesFrom1 Jan 2014 → 31 Dec 2017Funding: IWT personal funding - specialisation scholarships
Publications
1 - 10 of 10
- GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery(2023)
Authors: Loes van Schie, Wander Van Breedam, Charlotte Roels, Martin Frank, Ahmadreza Mehdipour, Bram Laukens, Wim Nerinckx, Francis Santens, Simon Devos, Iebe Rossey, et al.
- Yeast-produced fructosamine-3-kinase retains mobility after ex vivo intravitreal injection in human and bovine eyes as determined by Fluorescence Correlation Spectroscopy(2022)
Authors: An-Katrien Minnaert, Loes van Schie, Hendrik Grootaert, Jonas Himpe, Simon Devos, Wannes Weyts, Herlinde De Keersmaecker, Kevin Braeckmans, Katrien Remaut
- A potential role for fructosamine-3-kinase in cataract treatment(2021)
Authors: Sander De Bruyne, Loes van Schie, Jonas Himpe, Inge Everaert, Wim Derave, Caroline Van den Broecke, Manon Huizing, Nezahat Bostan, Marijn Speeckaert
- Exploration of synergistic action of cell wall-degrading enzymes against mycobacterium tuberculosis(2021)
Authors: Loes van Schie, Katlyn Borgers, Gitte Michielsen, Evelyn Plets, Marnik Vuylsteke, Petra Tiels, Nele Festjens
- Development of a counterselectable transposon to create markerless knockouts from an 18,432-clone ordered Mycobacterium bovis bacillus Calmette-Guérin mutant resource(2020)
Authors: Katlyn Borgers, Kristof Vandewalle, Annelies Van Hecke, Gitte Michielsen, Evelyn Plets, Loes van Schie, Sandrine Vanmarcke, Laurent Schindfessel, Nele Festjens, Nico Callewaert
- Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies (vol 181, pg 1004, 2020)(2020)
Authors: Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Loes van Schie, Markus Hoffmann, Stefan Pohlmann, Barney S. Graham, et al.
Pages: 1436 - 1441 - Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies(2020)
Authors: Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Gretel M. Torres, Nianshuang Wang, Wander Van Breedam, Loes van Schie, Markus Hoffmann, Stefan Poehlmann, Barney S. Graham, et al.
Pages: 1004 - 1015 - Exploring protein therapeutics to fight tuberculosis(2019)
Authors: Loes van Schie
- A simple colorimetric assay for measuring fructosamine 3 kinase activity(2017)
Authors: Justin C Cikomola, Antoine S Kishabongo, Karl Vandepoele, MARIEKE DE MULDER, Philippe B Katchunga, Bram Laukens, Loes van Schie, Hendrik Grootaert, Marijn Speeckaert
Pages: 154 - 163 - Structural basis of the proinflammatory signaling complex mediated by TSLP(2014)
Authors: Kenneth Verstraete, Loes van Schie, Laurens Vyncke, Yehudi Bloch, Jan Tavernier, Ewald Pauwels, Savvas Savvides
Pages: 375 - U115
Patents
1 - 5 of 5
- Compositions for use to treat cataract (Inventor)
- GLYCOSYLATED SINGLE CHAIN IMMUNOGLOBULIN DOMAINS (Inventor)
- Glycosylation of variable immunoglobulin domains (Inventor)
- Compositions for use to treat cataract (Inventor)
- Glycosylation of variable immunoglobulin domains (Inventor)